Carl Zeiss Meditec AG (fra:AFXA) Share Price

Company Profile

Business description
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world. Its ophthalmology segment, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, intraocular lenses, and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. The microsurgery segment is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% share, Zeiss is the clear leader in this market.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEU
T: +49 3641220115
https://www.zeiss.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2027
Employees
5,798

Recommended

The largest rare-earth producer outside of China acquires competitor to increase production.

Jon Mills, CFA | 05 October 2026

Draft IPO filing shows a company growing faster than its annual results can capture.

Harrison Rolfes | 05 October 2026

The stocks of these high-quality companies look cheap today.

Tori Brovet | 02 October 2026

Index	Last price	Change	% Change
All Ordinaries	8,903.50	44.30	0.50%
CAC 40	7,845.89	11.79	0.15%
DAX 40	25,435.43	181.22	0.72%
Dow JONES (US)	51,540.98	273.08	0.53%
FTSE 100	10,513.50	15.56	0.15%
HKSE	24,280.56	240.22	1.00%
NASDAQ	27,674.95	197.63	0.72%
Nikkei 225	70,683.98	737.12	1.05%
NZX 50 Index	13,700.12	1.10	0.01%
S&P 500	7,824.81	50.86	0.65%
S&P/ASX 200	8,735.70	49.30	0.57%
SSE Composite Index	3,842.19	11.74	0.31%